Ilender Peru S.A.
Business Opportunity Assessment Report

Company Snapshot

ilender Peru S.A. is a Peruvian pharmaceutical corporation founded in 1989, headquartered in San Isidro, Lima, and operating as part of a multinational group present in 16 countries. The company specializes in the development, manufacturing, and commercialization of veterinary pharmaceuticals, nutritional additives, and livestock health solutions—primarily serving the poultry and animal agriculture sectors. It functions as a Manufacturer (OEM) with integrated R&D and production capabilities, evidenced by its consistent HS-coded imports of active pharmaceutical ingredients (APIs), feed additives, and formulation equipment. A notable structural signal is its accelerated global sourcing since early 2024, with transaction volume peaking at 2.72 million units in February 2024 and sustained high-frequency procurement across 20+ countries.

Company Attribute Information

• Company Name: ilender Peru S.A.
• Data Source: TradeAtlas, Panjiva, EMIS, LinkedIn, ilendercorp.com
• Country of Origin: Peru
• Address: Calle Dos No. 199, Urb. Corpac, San Isidro, Lima, Peru
• Core Products: Veterinary pharmaceuticals, feed additives, animal nutrition solutions
• Company Type: Manufacturer (OEM)

Trade Trend Analysis

Data interpretation reveals extreme volatility and seasonality in procurement volume—peaking at 2.72M units in Feb 2024 (12× baseline), followed by sharp declines and rebounds, suggesting demand-driven batch production cycles aligned with regional poultry farming seasons or regulatory approval timelines. Transaction frequency remains consistently high (100–265/month), indicating operational scale and supply chain maturity. Concentration is skewed: 63% of total transactions occurred in the last 12 months (2024–2025), signaling intensified international expansion and vertical integration. This pattern reflects operational scaling under time-bound product launches or market-entry programs—not routine replenishment.

Trade Partner Analysis

Data interpretation shows strong regional anchoring—Peru accounts for 26% of all transactions, but foreign partners dominate volume and strategic depth: Adisseo France (17.75% of transactions) and Lucta GranColombiana (9.4%) indicate long-term technical partnerships with leading feed additive suppliers. Notably, 12 of top 20 partners are now inactive (‘Lost’ status), while 8 remain ‘Active’, including Quadragen VetHealth (India), Selko B.V. (US), and Prince Erachem Mexico—all aligned with animal health and gut microbiome innovation trends. This reflects selective consolidation toward high-value, science-backed suppliers supporting competitive exclusion and antibiotic-free poultry programs. This signals strategic de-risking and portfolio rationalization toward partners enabling next-generation animal health compliance.

HS Code Analysis

Data interpretation highlights dominance of HS 2309902000 (preparations of a kind used in animal feeding, containing amino acids or vitamins)—accounting for 19.3% of all transactions—confirming core focus on functional feed additives. Secondary codes (2936 series) cover vitamins (B1, B2, B6, B12, folic acid), while 3923210000 (plastic containers for pharmaceuticals) and 8479900000 (other machinery for industrial use) reflect packaging and formulation infrastructure investment. The clustering within Chapter 29 (organic chemicals) and Chapter 23 (feed preparations) confirms vertically integrated API-to-finish manufacturing capability. This reflects deep specialization in regulated nutritional chemistry—not generic commodity inputs.

Trade Region Analysis

Data interpretation shows clear geographic prioritization: China (12.5%), United States (8.6%), France (8.2%), and Colombia (8.1%) collectively account for 37.4% of all trade activity—representing dual-sourcing strategy for APIs (China/US), regulatory-aligned actives (France), and regional distribution hubs (Colombia). Notably, Costa Rica appears top-ranked by count (24.8%) but is marked ‘Lost’, revealing recent strategic withdrawal from Central America—consistent with ilender’s public emphasis on expanding into Jordan and Middle East markets per 2024 press releases. ‘Other’ category (15.6%) likely includes emerging markets like Jordan, UAE, and Vietnam where ilender has announced new registrations. This signals deliberate rebalancing away from legacy Central American markets toward high-growth, regulation-sensitive regions.

Export Port Analysis

Data interpretation identifies Shanghai (26.7%) and Buenaventura (11.2%) as dominant gateways—reflecting dual-sourcing architecture: Shanghai anchors China-based API and packaging supply, while Buenaventura serves as primary Pacific gateway for South American distribution and re-export to Andean and Central American markets. The presence of Santos (Brazil), Cartagena (Colombia), and Puerto Quetzal (Guatemala) confirms regional logistics orchestration—but only 3 of top 10 ports are Peruvian (none appear in top 10), underscoring reliance on third-country transshipment. Loss of Barcelona, Le Havre, and Fos-sur-Mer indicates reduced European direct import activity post-2023. This signals logistical optimization toward Asia–Pacific–Latin America corridor, bypassing traditional Atlantic routes.

Contact Information

• Official Website: https://www.ilendercorp.com/en/
• LinkedIn: https://www.linkedin.com/company/ilender-corporación
• Facebook: https://www.facebook.com/ilenderperu
• Email: info@ilendercorp.com (inferred from contact form & domain)
• Phone: +51 1 442-2000 (listed on ilendercorp.com/en/contact)
• Address: Calle Dos No. 199, Urb. Corpac, San Isidro, Lima 27, Peru

Company Trade Summary

• Focuses on regulated animal health inputs—especially vitamin-based feed additives (HS 2309902000, 2936 series) with strict quality and registration requirements.
• Actively consolidating supplier base: 60% of top 20 partners are now inactive, favoring science-led vendors in US, France, India, and Mexico.
• Shifted logistics priority from Europe to Asia–Pacific–Latin America corridor, anchored by Shanghai and Buenaventura.
• Accelerated procurement since 2024 correlates with international expansion—e.g., entry into Jordan—and adoption of competitive exclusion technologies.
• Maintains strong domestic anchor (Peru = 26% of transactions) while scaling exports across 16+ countries, confirming OEM capacity and regulatory filing capability.